Document:

Articles of Amendment

 EXHIBIT 4.1 
  
 MID-AMERICA APARTMENT COMMUNITIES, INC. 
  
 ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED CHARTER 
 DESIGNATING AND FIXING THE RIGHTS AND 
 PREFERENCES OF A SERIES OF SHARES OF
PREFERRED STOCK 
  
 Mid-America Apartment Communities, Inc., a
Tennessee corporation (the “Company”), certifies to the Tennessee Secretary of State that: 
  
 FIRST: Pursuant to the authority expressly vested in the Board of Directors of the Company by Section 6 of the Company’s Amended and Restated
Charter, as amended by Articles of Amendment dated January 28, 1994, Articles of Merger of the Cates Company with and into the Company dated February 2, 1994, Articles of Merger of America First REIT Advisory Company with and into the Company dated
June 29, 1995, Articles of Amendment to the Amended and Restated Charter Designating and Fixing the Rights and Preferences of a Series of Shares of Preferred Stock dated October 9, 1996, Articles of Amendment to the Amendment and Restated Charter
dated November 17, 1997, Articles of Amendment to the Amended and Restated Charter Designating and Fixing the Rights and Preferences of a Series of Shares of Preferred Stock dated November 17, 1997, Articles of Merger of Flournoy Development Company
with and into the Company dated November 21, 1997, Articles of Amendment to the Amended and Restated Charter dated December 15, 1997, Articles of Amendment to the Amended and Restated Charter Designating and Fixing the Rights and Preferences of a
Series of Shares of Preferred Stock dated June 25, 1998, Articles of Amendment to the Amended and Restated Charter Designating and Fixing the Rights and Preferences of a Series of Shares of Preferred Stock dated December 24, 1998, Articles of
Amendment to the Amended and Restated Charter Designating and Fixing the Rights and Preferences of a Series of Shares of Preferred Stock dated October 14, 2002, and Articles of Amendment to the Amended and Restated Charter Designating and Fixing the
Rights and Preferences of a Series of Shares of Preferred Stock dated October 28, 2002 (the “Charter”), and Section 48-16-102 of the Tennessee Code Annotated, as amended, the Board of Directors has, by resolution, duly divided and
classified 6,200,000 shares of the preferred stock of the Company into a series designated 8.30% Series H Cumulative Redeemable Preferred Stock (the “Series H Preferred Stock”) and has provided for the issuance of the Series H Preferred
Stock. The Company is authorized to issue up to 20,000,000 shares of preferred stock (“Preferred Stock”) in one or more series, with such designations, powers, preferences, conversion or other rights, voting powers, restrictions,
limitations as to dividends or other distributions, qualifications and terms or conditions of redemption, in each case, if any, as are permitted by Tennessee law and as the Board of Directors of the Company may determine by adoption of an amendment
of the Company’s Charter, without any further vote or action by the Company’s shareholders. 
  
 SECOND: Section 6 is hereby amended by adding the following: 
  

 The preferences, rights, voting powers, restrictions, limitations as to dividends, qualifications and terms and
conditions of redemption of the shares of Series H Preferred Stock are as follows: 
  
 1. Designation and Number. A series of Preferred Stock, designated the “8.30% Series H Cumulative Redeemable Preferred Stock” (the “Series H Preferred Stock”), is hereby established.
The number of shares of the Series H Preferred Stock shall be 6,200,000. 
  
 2. Maturity. The Series H Preferred Stock has no stated maturity and will not be subject to any sinking fund or mandatory redemption. 
  
 3. Rank. The Series H Preferred Stock, with respect to dividend rights and rights upon liquidation,
dissolution or winding up of the Company, will rank (i) senior to all classes or series of common stock of the Company, $.01 par value per share (the “Common Stock”), and to all equity securities ranking junior to the Series H Preferred
Stock with respect to dividend rights or rights upon liquidation, dissolution or winding up of the Company; (ii) on a parity with all equity securities issued by the Company, including the Company’s 9.5% Series A Cumulative Preferred Stock (the
“Series A Preferred Stock”), 8.875% Series B Cumulative Preferred Stock (the “Series B Preferred Stock”), the 9.375% Series C Cumulative Preferred Stock (the “Series C Preferred Stock”), the 9.5% Series E Cumulative
Preferred Stock (the “Series E Preferred Stock”), the 9 1⁄4% Series F Cumulative Preferred Stock (the “Series F Preferred Stock”) and the 8 5/8% Series G Cumulative Preferred Stock (the “Series G Preferred Stock”),
the terms of which specifically provide that such equity securities rank on a parity with the Series H Preferred Stock with respect to dividend rights or rights upon liquidation, dissolution or winding up of the Company (the “Parity Preferred
Stock”); and (iii) junior to all existing and future indebtedness of the Company. The term “equity securities” does not include convertible debt securities, which will rank senior to the Series H Preferred Stock prior to conversion.

  
 4. Dividends. 
  
 (a) Holders of shares of the Series H Preferred Stock are entitled to
receive, when and as declared by the Board of Directors (or a duly authorized committee thereof), out of funds legally available for the payment of dividends, preferential cumulative cash dividends at the rate of 8.30% per annum of the $25
liquidation preference (the “Liquidation Preference”) per share (equivalent to a fixed annual amount of $2.075 per share). Dividends on the Series H Preferred Stock shall be cumulative from the date of original issue and shall be payable
quarterly in arrears on or before the 23rd day of September, December, March and June, or, if not a business day, the next succeeding business day (each, a “Dividend Payment Date”). The first dividend, which will be payable on September
23, 2003, will be for less than a full quarter. Such dividend and any dividend payable on the Series H Preferred Stock for any partial dividend period will be computed on the basis of a 360-day year consisting of four 90-day quarters. Dividends will
be payable to holders of record as they appear in the stock records of the Company at the close of business on the applicable record date, which shall be such date designated by the Board of Directors of the Company that is not more than 30 nor less
than 10 days prior to such Dividend Payment Date (each, a “Dividend Record Date”). 
  

 (b) No dividends on shares of Series H Preferred Stock shall be declared by the Board of Directors or
paid or set apart for payment by the Company at such time as the terms and provisions of any agreement of the Company, including any agreement relating to its indebtedness, prohibits such declaration, payment or setting apart for payment or provides
that such declaration, payment or setting apart for payment would constitute a breach thereof or a default thereunder, or if such declaration or payment shall be restricted or prohibited by law. 
  
 (c) Notwithstanding the foregoing, dividends on the Series H Preferred Stock
will accumulate whether or not the Company has earnings, whether or not there are funds legally available for the payment of such dividends and whether or not such dividends are declared. Accumulated but unpaid dividends on the Series H Preferred
Stock will not bear interest and holders of the Series H Preferred Stock will not be entitled to any distributions in excess of full cumulative distributions described above. Except as set forth in the next sentence, no dividends will be declared or
paid or set apart for payment on any capital stock of the Company or any other series of Parity Preferred Stock or any series or class of equity securities ranking junior to the Series H Preferred Stock (other than a dividend in shares of the
Company’s Common Stock or in shares of any other class of stock ranking junior to the Series H Preferred Stock as to dividends and upon liquidation) for any period unless full cumulative dividends have been or contemporaneously are declared and
paid or declared and a sum sufficient for the payment thereof is set apart for such payment on the Series H Preferred Stock for all past dividend periods and the then current dividend period. When dividends are not paid in full (or a sum sufficient
for such full payment is not so set apart) upon the Series H Preferred Stock and the shares of any other series of Parity Preferred Stock, all dividends declared upon the Series H Preferred Stock and any other series of Parity Preferred Stock, shall
be declared pro rata so that the amount of dividends declared per share of Series H Preferred Stock and such other series of Parity Preferred Stock shall in all cases bear to each other the same ratio that accumulated dividends per share on the
Series H Preferred Stock and such other series of Parity Preferred Stock (which shall not include any accrual in respect of unpaid dividends for prior dividend periods if such Parity Preferred Stock does not have a cumulative dividend) bear to each
other. 
  
 (d) Except as provided in the immediately preceding
paragraph, unless full cumulative dividends on the Series H Preferred Stock have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof is set apart for payment for all past dividend periods and the
then current dividend period, no dividends (other than in shares of Common Stock or other shares of capital stock ranking junior to the Series H Preferred Stock as to dividends and upon liquidation) shall be declared or paid or set aside for payment
nor shall any other distribution be declared or made upon the Common Stock, or any other capital stock of the Company ranking junior to or on a parity with the Series H Preferred Stock as to dividends or upon liquidation, nor shall any shares of
Common Stock, or any other shares of capital stock of the Company ranking junior to or on a parity with the Series H Preferred Stock as to dividends or upon liquidation be redeemed, purchased or otherwise acquired for any consideration (or any
monies be paid to or made available for a sinking fund for the redemption of any such shares) by the Company (except by conversion into or exchange for other capital stock of the Company ranking junior to the Series H Preferred Stock as to dividends
and upon liquidation or redemption for the purpose of preserving the Company’s qualification as a real estate investment trust (“REIT”)). Holders of shares of the Series H Preferred Stock shall 
  

 not be entitled to any dividend, whether payable in cash, property or stock, in excess of full cumulative dividends on
the Series H Preferred Stock as provided above. Any dividend payment made on shares of the Series H Preferred Stock shall first be credited against the earliest accumulated but unpaid dividend due with respect to such shares which remains payable.

  
 5. Liquidation Preference. Upon any voluntary or
involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares of Series H Preferred Stock are entitled to be paid out of the assets of the Company legally available for distribution to its shareholders a
liquidation preference of $25 per share, plus an amount equal to any accumulated and unpaid dividends to the date of payment, but without interest, before any distribution of assets is made to holders of Common Stock or any other class or series of
capital stock of the Company that ranks junior to the Series H Preferred Stock as to liquidation rights. If the assets of the Company legally available for distribution to shareholders are insufficient to pay in full the Liquidation Preference on
the Series H Preferred Stock and the Liquidation Preference on any shares of Parity Preferred Stock, all assets distributed to the holders of the Series H Preferred Stock and any other series of Parity Preferred Stock shall be distributed pro rata
so that the amount of assets distributed per share of Series H Preferred Stock and such other series of Parity Preferred Stock shall in all cases bear to each other the same ratio that the Liquidation Preference per share on the Series H Preferred
Stock and such other series of Parity Preferred Stock bear to each other. Holders of Series H Preferred Stock will be entitled to written notice of any event triggering the right to receive such Liquidation Preference. After payment of the full
amount of the Liquidation Preference, plus any accumulated and unpaid dividends to which they are entitled, the holders of Series H Preferred Stock will have no right or claim to any of the remaining assets of the Company. The consolidation or
merger of the Company with or into any other corporation, trust or entity or of any other corporation with or into the Company, or the sale, lease or conveyance of all or substantially all of the property or business of the Company, shall not be
deemed to constitute a liquidation, dissolution or winding up of the Company. 
  
 6. Redemption. 
  
 (a) The Series H Preferred Stock is not redeemable prior to August 11, 2008. However, in order to ensure that the Company will continue to meet the requirement for qualification as a REIT, the Series H Preferred Stock will be subject to
provisions in the Company’s Charter (the “Charter”) pursuant to which shares of capital stock of the Company owned by a shareholder in excess of 9.9% in value of the outstanding shares of capital stock of the Company (the
“Ownership Limit”) will be deemed “Excess Shares,” and the Company will have the right to purchase such Excess Shares from the holder. On and after August 11, 2008, the Company, at its option upon not less than 30 nor more than
60 days’ written notice, may redeem shares of the Series H Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25 per share, plus all accumulated and unpaid dividends thereon to the date
fixed for redemption (except with respect to Excess Shares), without interest. Holders of Series H Preferred Stock to be redeemed shall surrender such Series H Preferred Stock at the place designated in such notice and upon such surrender shall be
entitled to the redemption price and any accumulated and unpaid dividends payable upon such redemption. If notice of redemption of any shares of Series H Preferred Stock has been given and if the funds necessary for such redemption have been set
aside by the Company in trust for the benefit of the 
  

 holders of any shares of Series H Preferred Stock shall no longer be deemed outstanding and all rights of the holders of
such shares will terminate, except the right to receive the redemption price. If less than all of the outstanding Series H Preferred Stock is to be redeemed shall be selected pro rata (as nearly as may be practicable without creating fractional
shares) or by any other equitable method determined by the Company. After redemption, all shares of Series H Preferred Stock previously outstanding shall be unclassified and shall constitute authorized and unissued shares of the Company’s
preferred stock that may be designated by the Company’s Board of Directors pursuant to Article 6 of the Company’s Second Amended and Restated Charter, as further amended. 
  
 (b) Unless full cumulative dividends on all shares of Series H Preferred Stock shall have been or contemporaneously are
declared and paid or declared and a sum sufficient for the payment thereof set apart for payment for all past dividend periods and the then current dividend period, no shares of Series H Preferred Stock shall be redeemed unless all outstanding
shares of Series H Preferred Stock are simultaneously redeemed and the Company shall not purchase or otherwise acquire directly or indirectly any shares of Series H Preferred Stock (except by exchange for capital stock of the Company ranking junior
to the Series H Preferred Stock as to dividends and upon liquidation); provided, however, that the foregoing shall not prevent the purchase by the Company of Excess Shares in order to ensure that the Company continues to meet the requirements for
qualification as a REIT, or the purchase or acquisition of shares of Series H Preferred Stock pursuant to a purchase or exchange offer made on the same terms to holders of all outstanding shares of Series H Preferred Stock. So long as no dividends
are in arrears, the Company shall be entitled at any time and from time to time to repurchase shares of Series H Preferred Stock in open-market transactions duly authorized by the Board of Directors and effected in compliance with applicable laws.

  
 (c) Notice of redemption will be given by publication in a
newspaper of general circulation in the City of New York, such publication to be made once a week for two successive weeks commencing not less than 30 nor more than 60 days prior to the redemption date. A similar notice will be mailed by the
Company, postage prepaid, not less than 30 nor more than 60 days prior to the redemption date, addressed to the respective holders of record of the Series H Preferred Stock to be redeemed at their respective addresses as they appear on the stock
transfer records of the Company. No failure to give such notice or any defect therein or in the mailing thereof shall affect the validity of the proceedings for the redemption of any shares of Series H Preferred Stock except as to the holder to whom
notice was defective or not given. Each notice shall state: (i) the redemption date; (ii) the redemption price, (iii) the number of shares of Series H Preferred Stock to be redeemed; (iv) the place or places where the Series H Preferred Stock is to
be surrendered for payment of the redemption price; and (v) that dividends on the shares to be redeemed will cease to accrue on such redemption date. If less than all of the Series H Preferred Stock held by any holder is to be redeemed, the notice
mailed to such holder shall also specify the number of shares of Series H Preferred Stock held by such holder to be redeemed. 
  
 (d) Immediately prior to any redemption of Series H Preferred Stock, the Company shall pay, in cash, any accumulated and unpaid dividends through the
redemption date, unless a redemption date falls after a Dividend Record Date and prior to the corresponding 
  

 Dividend Payment Date, in which case each holder of Series H Preferred Stock at the close of business on such Dividend
Record Date shall be entitled to the dividend payable on such shares on the corresponding Dividend Payment Date notwithstanding the redemption of such shares before such Dividend Payment Date. 
  
 (e) The Series H Preferred Stock has no stated maturity and will not be
subject to any sinking fund or mandatory redemption. However, in order to ensure that the Company continues to meet the requirements for qualification as a REIT, Series H Preferred Stock acquired by a shareholder in excess of the Ownership Limit
will automatically become Excess Shares, and the Company will have the right to purchase such Excess Shares from the holder. In addition, Excess Shares may be redeemed, in whole or in part, at any time when outstanding shares of Series H Preferred
Stock are being redeemed, for cash at a redemption price of $25 per share, but excluding accumulated and unpaid dividends on such Excess Shares, without interest. Such Excess Shares shall be redeemed in such proportion and in accordance with such
procedures as shares of Series H Preferred Stock are being redeemed. 
  
 7. Voting Rights. 
  
 (a) Holders of the
Series H Preferred Stock will not have any voting rights, except as set forth below or as otherwise from time to time required by law. 
  
 (b) Whenever dividends on any shares of Series H Preferred Stock shall be in arrears for eighteen or more months (a “Preferred Dividend
Default”), the holders of such shares of Series H Preferred Stock voting separately as a class together with the holders of the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series F Preferred Stock,
the Series G Preferred Stock and all other series of Parity Preferred Stock upon which like voting rights have been conferred and are exercisable will be entitled to vote separately as a class for the election of a total of two additional directors
of the Company (the “Preferred Stock Directors”) at a special meeting called by the holders of record of at least 20% of the Series H Preferred Stock or the holders of record of at least 20% of any series of Parity Preferred so in arrears
(unless such request is received less than 90 days before the date fixed for the next annual or special meeting of the shareholders) or at the next annual meeting of shareholders, and at each subsequent annual meeting until all dividends accumulated
on such shares of Series H Preferred Stock for the past dividend periods and the dividend for the then current dividend period shall have been fully paid or declared and a sum sufficient for the payment thereof set aside for payment. A quorum for
any such meeting shall exist if at least a majority of the outstanding shares of Series H Preferred Stock and shares of Parity Preferred Stock upon which like voting rights have been conferred and are exercisable are represented in person or by
proxy at such meeting. The Preferred Stock Directors shall be elected upon the affirmative vote of a plurality of the shares of Series H Preferred Stock and such Parity Preferred Stock present and voting in person or by proxy at a fully called and
held meeting at which a quorum is present voting separately as a class. If and when all accumulated dividends and the dividend for the then current dividend period on the Series H Preferred Stock shall have been paid in full or declared and set
aside for payment in full, the holders thereof shall be divested of the foregoing voting rights (subject to revesting in the event of each and every Preferred Dividend Default) and, if all accumulated dividends and the dividend for the then current

  

 dividend period have been paid in full or declared and set aside for payment in full on all series of Parity Preferred
Stock upon which like voting rights have been conferred and are exercisable, the term of office of each Preferred Stock Director so elected shall terminate. Any Preferred Stock Director may be removed at any time with or without cause by, and shall
not be removed otherwise than by the vote of, the holders of record of a majority of the outstanding shares of the Series H Preferred Stock when they have the voting rights described above (voting separately as a class with all series of Parity
Preferred Stock upon which like voting rights have been conferred and are exercisable). So long as a Preferred Dividend Default shall continue, any vacancy in the office of a Preferred Stock Director may be filled by written consent of the Preferred
Stock Director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the outstanding shares of Series H Preferred Stock when they have the voting rights described above (voting separately as a class
with all series of Parity Preferred Stock upon which like voting rights have been conferred and are exercisable). The Preferred Stock Directors shall be entitled to one vote per director on any matter. 
  
 (c) So long as any shares of Series H Preferred Stock remain outstanding, the
Company will not, without the affirmative vote or consent of the holders of at least two-thirds of the shares of the Series H Preferred Stock outstanding at the time, given in person or by proxy, either in writing or at a meeting (voting separately
as a class), amend, alter or repeal the provisions of the Charter or the Designating Amendment, whether by merger, consolidation or otherwise (an “Event”), so as to materially and adversely affect any right, preference, privilege or voting
power of the Series H Preferred Stock of the holders thereof; provided, however, that with respect to the occurrence of any Event set forth above, so long as the Series H Preferred Stock remains outstanding with the terms thereof materially
unchanged, the occurrence of any such Event shall not be deemed to materially and adversely affect such rights, preferences, privileges or voting power of holders of the Series H Preferred Stock and provided, further that (i) any increase in the
amount of the authorized Preferred Stock or the creation or issuance of any other series of Preferred Stock, or (ii) any increase in the amount of authorized shares of such series, in each case ranking on a parity with or junior to the Series H
Preferred Stock with respect to payment of dividends or the distribution of assets upon liquidation, dissolution or winding up, shall not be deemed to materially and adversely affect such rights, preferences, privileges or voting powers. 

 
 (d) The foregoing voting provisions will not apply if, at or prior to the
time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding shares of Series H Preferred Stock shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have
been deposited in trust to effect such redemption. 
  
 8.
Conversion. The Series H Preferred Stock is not convertible into or exchangeable for any other property or securities of the Company. 
  
 THIRD: This Designating Amendment shall be effective at the time Tennessee Secretary of State accepts this Designating Amendment for filing. 

 

 FOURTH: The foregoing amendment was duly adopted by unanimous consent of the board of directors without
shareholder action, such shareholder action not being required, on June 23, 2003. 
  
 IN WITNESS WHEREOF, MID-AMERICA APARTMENT COMMUNITIES, INC. has caused these presents to be signed in its name and on its behalf by its Chief Financial Officer on this the
             day of July, 2003. 
  

	 	 	 MID-AMERICA APARTMENT
 COMMUNITIES,
INC.
  
  
 By:

 Title:    Chief Financial OfficerStock Purchase Agreement

 EXHIBIT 10.1 
  
  
  
  
 SERIES B PREFERRED STOCK PURCHASE AGREEMENT 
  
  
 BY AND AMONG 
  
  
 PRICESMART, INC. 
  
  
 and 
  
  
 THE INVESTORS LISTED ON 
 EXHIBIT A ATTACHED HERETO 
  
  
  
  
 Dated as of July 8, 2003 
  

 TABLE OF CONTENTS 
  

			
	1.	 	 AUTHORIZATION AND SALE OF THE SHARES
	  	1
				
	 	 	 1.1
	  	Authorization of the Shares	  	1
				
	 	 	 1.2
	  	Sale of the Shares	  	1
			
	2.	 	 CLOSING
	  	1
			
	3.	 	 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	2
				
	 	 	 3.1
	  	Organization, Good Standing and Qualification	  	2
				
	 	 	 3.2
	  	Authorization	  	2
				
	 	 	 3.3
	  	Valid Issuance of the Securities	  	3
				
	 	 	 3.4
	  	Capitalization	  	3
				
	 	 	 3.5
	  	Noncontravention	  	4
				
	 	 	 3.6
	  	Reports Filed Under the Securities Exchange Act of 1934; Financial Statements	  	5
				
	 	 	 3.7
	  	Absence of Certain Changes	  	5
				
	 	 	 3.8
	  	No General Solicitation	  	5
				
	 	 	 3.9
	  	Disclosure	  	5
			
	4.	 	 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS
	  	6
				
	 	 	 4.1
	  	Organization and Qualification	  	6
				
	 	 	 4.2
	  	Authorization	  	6
				
	 	 	 4.3
	  	Purchase for Own Account	  	6
				
	 	 	 4.4
	  	Accredited Investor Status	  	6
				
	 	 	 4.5
	  	Restricted Securities	  	7
				
	 	 	 4.6
	  	Due Diligence and No Solicitation	  	7
				
	 	 	 4.7
	  	Further Limitations on Disposition	  	7
				
	 	 	 4.8
	  	Legends	  	7
			
	5.	 	 PRE-CLOSING COVENANTS OF THE PARTIES
	  	8
				
	 	 	 5.1
	  	General	  	8
				
	 	 	 5.2
	  	Notice of Developments	  	8
			
	6.	 	 POST-CLOSING COVENANTS OF THE PARTIES
	  	8
				
	 	 	 6.1
	  	Status of Dividends	  	8
				
	 	 	 6.2
	  	Listing; Reservation	  	8
			
	7.	 	 CONDITIONS TO THE INVESTORS’ OBLIGATIONS AT CLOSING
	  	9
				
	 	 	 7.1
	  	Representations and Warranties True	  	9
				
	 	 	 7.2
	  	Compliance with Covenants	  	9
				
	 	 	 7.3
	  	No Litigation	  	9
				
	 	 	 7.4
	  	Securities Exemptions	  	9
				
	 	 	 7.5
	  	Certificate of Designations	  	9
				
	 	 	 7.6
	  	Shares	  	10
				
	 	 	 7.7
	  	Proceedings	  	10
				
	 	 	 7.8
	  	No Material Adverse Effect	  	10

  

 ii 

			
	8.	  	 CONDITIONS TO THE COMPANY’S OBLIGATIONS AT CLOSING
	  	10
				
	 	  	 8.1
	  	Representations and Warranties True	  	10
				
	 	  	 8.2
	  	Payment of Consideration	  	10
				
	 	  	 8.3
	  	No Litigation	  	10
				
	 	  	 8.4
	  	Securities Exemptions	  	11
			
	9.	  	 REGISTRATION STATEMENT FOR RESALE OF THE SHARES
	  	11
				
	 	  	 9.1
	  	Registration	  	11
				
	 	  	 9.2
	  	Company Obligations	  	11
				
	 	  	 9.3
	  	Restrictions on Registrations	  	12
				
	 	  	 9.4
	  	Investor Obligations and Rights	  	13
				
	 	  	 9.5
	  	Indemnification	  	14
				
	 	  	 9.6
	  	Expenses	  	16
			
	10.	  	 TERMINATION
	  	17
				
	 	  	 10.1
	  	Termination	  	17
				
	 	  	 10.2
	  	Effect of Termination	  	17
			
	11.	  	 MISCELLANEOUS
	  	17
				
	 	  	 11.1
	  	Survival of Warranties	  	17
				
	 	  	 11.2
	  	Specific Performance	  	17
				
	 	  	 11.3
	  	Successors and Assigns	  	18
				
	 	  	 11.4
	  	Governing Law	  	18
				
	 	  	 11.5
	  	Counterparts	  	18
				
	 	  	 11.6
	  	Headings	  	18
				
	 	  	 11.7
	  	Notices	  	19
				
	 	  	 11.8
	  	No Finder’s Fees	  	19
				
	 	  	 11.9
	  	Amendments and Waivers	  	20
				
	 	  	 11.10
	  	Attorneys’ Fees	  	20
				
	 	  	 11.11
	  	Severability	  	20
				
	 	  	 11.12
	  	Entire Agreement	  	20
				
	 	  	 11.13
	  	No Third Party Beneficiaries	  	20
				
	 	  	 11.14
	  	Public Announcements	  	20
				
	 	  	 11.15
	  	Further Assurances	  	20
				
	 	  	 11.16
	  	Fees and Expenses	  	20
				
	 	  	 11.17
	  	Waiver of Jury Trial	  	21
		
	SCHEDULES	  	 
		
	Schedule 3.4(b)	  	 
		
	EXHIBITS	  	 
		
	Exhibit A        Schedule of Investors	  	 
		
	Exhibit B        Certificate of Designations	  	 

  

 iii 

 SERIES B PREFERRED STOCK PURCHASE AGREEMENT 
  
 This SERIES B PREFERRED STOCK PURCHASE AGREEMENT (including the Exhibits and
Schedules hereto, this “Agreement”) is made and entered into as of July 8, 2003 by and among PriceSmart, Inc., a Delaware corporation (the “Company”), and the investors listed on Exhibit A attached hereto
(each an “Investor” and, collectively, the “Investors”). The Investors and the Company are referred to herein individually as a “Party” and together as the “Parties.” 
  
 W I T N E S S E T H:

  
 WHEREAS, the Company desires to sell to the Investors, and the
Investors desire to purchase from the Company, an aggregate of 22,000 shares of the Company’s Series B Preferred Stock, par value $.0001 per share (the “Series B Preferred”), on the terms and conditions set forth in this
Agreement. 
  
 NOW, THEREFORE, in consideration of the premises
and the mutual promises contained herein and for good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows: 
  
 1. AUTHORIZATION AND SALE OF THE SHARES 
  
 1.1 Authorization of the Shares. The Company has authorized a new series of preferred stock, designated 8% Series B
Cumulative Convertible Redeemable Preferred Stock, such series having the rights, preferences and privileges provided for in the Company’s Certificate of Designations, Preferences and Relative, Participating, Optional and Other Special Rights
of 8% Series B Cumulative Convertible Redeemable Preferred Stock and Qualifications, Limitations and Restrictions Thereof, a form of which is attached hereto as Exhibit B (the “Series B Certificate”). In addition, the Company
has authorized the issuance and sale to the Investors of an aggregate of 22,000 shares of the Series B Preferred (the “Shares”). 
  
 1.2 Sale of the Shares. Subject to the terms and conditions of this Agreement, the Company agrees to sell to each of the Investors at the Closing,
and each of the Investors severally agrees to purchase from the Company at the Closing, that number of Shares set forth opposite each such Investor’s name on Exhibit A attached hereto at a purchase price of $1,000 per share (the
“Purchase Price”). The shares of the Company’s common stock, par value $.0001 per share (the “Common Stock”), issued or issuable upon conversion of the Shares are referred to as the “Conversion
Shares.” The Shares and the Conversion Shares are collectively referred to as the “Securities.” 
  
 2. CLOSING. The purchase and sale of the Shares (the “Closing”) will take place at the offices of Latham & Watkins LLP,
12636 High Bluff Drive, Suite 300, San Diego, CA 92130 at 10:00 a.m. Pacific Time, on July 9, 2003, or at such other time and place mutually agreed upon by the Parties, or if any of the conditions set forth in Section 7 (other than conditions with
respect to actions the respective Parties will take at the Closing itself) has not been satisfied, a later date selected by the Investors, which date shall be within five (5) Business Days (as defined below) following the satisfaction or waiver of
all conditions to the obligations 
  

 1 

 of the Parties to consummate the transactions to occur at the Closing (other than conditions with respect to actions the
respective Parties will take at the Closing itself) (such date, the “Closing Date”). “Business Day” means any day, other than a Saturday, Sunday or a day on which banking institutions in the State of California are
authorized or obligated by law, regulation or executive order to close. At the Closing, the Company will deliver to each of the Investors (i) a certificate registered in the Investor’s name and in the denominations designated by such Investor
prior to the Closing Date representing the Shares and (ii) the other documents and certificates to be delivered pursuant to Section 7 hereof, all against payment of the Purchase Price by wire transfer of immediately available funds as directed
pursuant to instructions delivered by the Company to the Investors prior to the Closing Date. The number of Shares to be purchased at the Closing by each Investor and the portion of aggregate Purchase Price to be paid by each Investor are set forth
next to each Investor’s name on Exhibit A hereto. 
  
 3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby represents and warrants to, and agrees with, the Investors that the statements in the following paragraphs of this Section 3 are true and correct:

  
 3.1 Organization, Good Standing and Qualification. Each
of the Company and its Subsidiaries (as defined below) is a corporation, partnership or limited liability company duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has all requisite
power and authority to own or lease and operate its properties and to conduct its business as it is currently being conducted and is proposed to be conducted. Each of the Company and its Subsidiaries is duly licensed, authorized or qualified as a
foreign corporation, partnership or limited liability company for the transaction of business and is in good standing under the laws of each other jurisdiction in which its ownership, lease or operation of property or conduct of business requires
such qualification, except where the failure to be so qualified would not have a material adverse effect on the assets, liabilities, condition (financial or otherwise), results of operations, prospects or business of the Company and its Subsidiaries
taken as a whole (“Material Adverse Effect”). The Company is not in default under or in violation of any provision of its amended and restated certificate of incorporation (the “Certificate of Incorporation”) or its
bylaws (the “Bylaws”). “Subsidiary” means as to any Person (as defined below), any other Person of which more than 50% of the shares of the voting stock or other voting interests are owned or controlled, or the
ability to select or elect more than 50% of the directors or similar managers is held, directly or indirectly, by such first Person or one or more of its Subsidiaries or by such first Person and one or more of its Subsidiaries.
“Person” means any individual, corporation, company, association, partnership, limited liability company, joint venture, trust, unincorporated organization or Governmental Authority (as defined below). 
  
 3.2 Authorization. The Company has all requisite power and authority
to execute and deliver this Agreement and to perform its obligations hereunder. All corporate action on the part of the Company necessary for the authorization, execution and delivery of this Agreement, the performance of the obligations of the
Company at the Closing, the performance of the obligations of the Company under Section 9 hereof and the issuance and delivery of the Securities has been taken, and this Agreement has been duly executed and delivered by the Company and constitutes a
valid and legally binding obligation of the Company, enforceable in accordance with its terms, except as may be limited by (i) applicable bankruptcy, insolvency, reorganization or other laws of general application relating to or affecting the
enforcement of 
  

 2 

 creditors’ rights generally; (ii) the effect of rules of law governing the availability of equitable remedies; and
(iii) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to
public policy or prohibited by law. 
  
 3.3 Valid Issuance of
the Securities. 
  
 (a) The Shares have been duly and validly
authorized, reserved for issuance and, when issued, sold and delivered by the Company in accordance with the terms of this Agreement for the consideration provided for herein, will have been duly and validly issued, will be fully paid and
nonassessable and will be free of any mortgage, pledge, lien, security interest, claim, voting agreement, conditional sale agreement, title retention agreement, restriction, option or encumbrance of any kind, character or description whatsoever
(“Lien”) (other than those that may be created by the Investors) and free of any restrictions on transfer other than restrictions on transfer under applicable federal and state securities laws and, assuming the truth and correctness
of the Investors’ representations and warranties in Section 4 below, will be issued in compliance with all applicable federal and state securities laws. 
  
 (b) The Conversion Shares have been duly and validly authorized by the Company and reserved for issuance and, when issued in accordance with the terms of
the Series B Certificate, will have been duly and validly issued, will be fully paid and nonassessable and will be free of any Liens (other than those that may be created by the Investors) and free of any restrictions on transfer other than
restrictions on transfer under applicable federal and state securities laws and will be issued in compliance with all applicable federal and state securities laws. 
  
 3.4 Capitalization. 
  
 (a) The entire authorized capital stock of the Company consists of 15,000,000 shares of Common Stock, of which 6,871,913 shares (not including 413,650
shares held by the Company as treasury shares) were issued and outstanding as of July 3, 2003, and 2,000,000 shares of preferred stock, par value $.0001 per share, of which 20,000 shares of the Company’s 8% Series A Cumulative Convertible
Redeemable Preferred Stock, and not including the Shares issued pursuant to this Agreement, are issued and outstanding as of the date of this Agreement. Except as set forth in the SEC Documents (as defined below) and except as contemplated hereby,
there are no outstanding or authorized warrants, options, purchase rights, subscription rights, conversion rights, exchange rights or other contracts, commitments or obligations that could require the Company or any of its Subsidiaries to issue,
grant, deliver or sell or otherwise cause to be issued, granted, delivered or sold or become outstanding any capital stock of the Company or any of its Subsidiaries, except for those granted in the ordinary course of business since the dates of the
SEC Documents. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or similar rights with respect to the Company or any of its Subsidiaries. To the Company’s knowledge, there are no voting trusts,
proxies or other agreements or understandings with respect to the voting of the capital stock of the Company. 
  

 3 

 (b) Except as set forth on Schedule 3.4(b) hereto, the registration of the Conversion Shares pursuant to
Section 9 hereof will not give rise to any registration rights on behalf of any Person under any agreement or instrument applicable to the Company. Except as set forth on Schedule 3.4(b) hereto, other than pursuant to Section 9 hereof, no Person has
any right to require the Company to register securities of the Company under the Securities Act of 1933, as amended (the “1933 Act”). 
  
 3.4 Noncontravention. 
  
 (a) Neither the execution and delivery of this Agreement, nor the consummation of the transactions contemplated hereby, will (i) violate any
constitution, statute, regulation, rule, ordinance, code, injunction, judgment, order, decree, ruling, charge, writ, determination or other restriction (“Law”) of any government or political subdivision or department thereof, any
governmental regulatory body, commission, board, agency or instrumentality, or any court or arbitrator or alternative dispute resolution body, in each case whether federal, state, local or foreign (“Governmental Authority”) to which
the Company or any of its Subsidiaries is subject or any provision of the Certificate of Incorporation or the Bylaws or the certificate of incorporation or bylaws or similar constituent documents of the Company’s Subsidiaries or (ii) conflict
with, result in a breach or violation of, constitute a default (with or without notice or the passage of time) under, result in the acceleration of, create in any party the right to accelerate, terminate, modify or cancel, or give rise to a right to
put or to compel a tender offer for outstanding securities of the Company or any of its Subsidiaries or require any notice, consent, waiver or approval under any agreement, contract, lease, license, loan, debt instrument, note, bond, indenture,
mortgage, deed of trust, joint venture agreement, approval of a Governmental Authority or other arrangement to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of the
Company’s or its Subsidiaries’ assets is subject (or result in the imposition of any mortgage, pledge, Lien, encumbrance, charge or other security interest upon any of such assets or properties), except in either case, where such
violation, conflict or default would not have a Material Adverse Effect. 
  
 (b) Except for filings which may be required under state securities laws, for which filings the Company shall be responsible, neither the Company nor any of its Subsidiaries is required to give any notice to, make any
filing or registration with, or obtain any authorization, consent or approval of any Governmental Authority in connection with the execution, delivery and performance by the Company of this Agreement and the transactions contemplated hereby
(including the issuance of Common Stock upon conversion of the Series B Preferred). 
  
 (c) No consent or approval of the Company’s stockholders is required by Law, the Certificate of Incorporation, the Bylaws, the rules and regulations of the Nasdaq Stock Market, or otherwise, for the execution,
delivery and performance by the Company of this Agreement and the consummation of the transactions contemplated hereby (including the issuance of Common Stock upon conversion of the Series B Preferred). 
  
 (d) The execution, delivery and performance of this Agreement by the Company
and the consummation of transactions contemplated hereby will not constitute a 
  

 4 

 “Change of Control” as such term is defined in any contract, agreement, indenture, mortgage, note, lease or
other instrument to which the Company or any of its Subsidiaries is a party or by which the Company or any such Subsidiary is bound or to which the properties of the Company or any such Subsidiary is subject. 
  
 3.5 Reports Filed Under the Securities Exchange Act of 1934; Financial
Statements. 
  
 (a) The Company has timely filed with the
Securities and Exchange Commission (the “SEC”) all reports required to be filed by the Company under the Securities Exchange Act of 1934, as amended (the “1934 Act”). All such reports filed by the Company with the
SEC in the preceding twelve (12) months (the “SEC Documents”) (i) comply in all material respects, with the applicable requirements of the 1934 Act and the 1933 Act, and (ii) contain all statements required to be stated therein in
accordance with the 1934 Act and do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. 
  
 (b) As of their respective dates (except as they have been correctly
amended), the financial statements of the Company included in the SEC Documents (i) complied in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, (ii) have been
prepared in accordance with United States generally accepted accounting principles, consistently applied, during the periods involved (except (A) as may be otherwise indicated in such financial statements or the notes thereto or (B) in the case of
unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and (iii) fairly present the financial position of the Company and its Subsidiaries as of the dates thereof and the results of its
operations and cash flows of the Company and its Subsidiaries (on a consolidated basis) for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). 
  
 3.6 Absence of Certain Changes. Except as disclosed in the SEC
Documents or otherwise disclosed in public announcements or press releases, since August 31, 2002, the Company and its Subsidiaries have conducted their consolidated business in the ordinary and usual course and there has been no change to the
business, properties, assets, operations, prospects, results of operations or condition (financial or otherwise) of the Company or its Subsidiaries (taken as a whole), except for such changes which could not be reasonably expected to have a Material
Adverse Effect. 
  
 3.7 No General Solicitation. Neither
the Company, nor any of its Affiliates (as defined below), nor any person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D (“Regulation D”)
promulgated under the 1933 Act) in connection with the offer or sale of the Shares. “Affiliate” has the meaning set forth in Rule 12b-2 promulgated under the 1934 Act as in effect on the date hereof. The term
“Affiliated” has a correlative meaning. 
  
 3.8
Disclosure. No information that has been provided to the Investors by the Company or any of its representatives in connection with the transactions contemplated by this Agreement, and no exhibit, document, statement, certificate or schedule
furnished or to be 
  

 5 

 furnished to the Investors pursuant to this Agreement, contains or will contain, as the case may be, any untrue statement
of a material fact, or omits or will omit, as the case may be, to state a material fact necessary to make the statements or facts contained therein not misleading. 
  
 4. REPRESENTATIONS AND WARRANTIES OF THE INVESTORS. Each of the Investors severally and not jointly represents
and warrants to the Company that the statements in the following paragraphs of this Section 4 are true and correct with respect to such Investor: 
  
 4.1 Organization and Qualification. The Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization. The Investor has all requisite power and authority to enter into and perform this Agreement and to carry out the transactions contemplated by this Agreement. 
  
 4.2 Authorization. All action on the part of the Investor necessary for the authorization, execution and delivery of
this Agreement and the performance of all obligations of the Investor hereunder has been taken, and this Agreement has been duly executed and delivered by the Investor and constitutes a valid and legally binding obligation of the Investor,
enforceable in accordance with its terms, except as may be limited by (a) applicable bankruptcy, insolvency, reorganization or other laws of general application relating to or affecting the enforcement of creditors’ rights generally; (b) the
effect of rules of law governing the availability of equitable remedies; and (c) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect
to a liability where such indemnification or contribution is contrary to public policy or prohibited by law. 
  
 4.3 Purchase for Own Account. Except as permitted pursuant to Section 11.3 hereof, the Securities to be acquired by the Investor hereunder will be
acquired for investment for the Investor’s own account, not as a nominee or agent, and not with a view to the public resale or distribution thereof within the meaning of the 1933 Act, and the Investor has no present intention of selling or
otherwise distributing the same. The Investor does not have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to the Securities. The
Investor also represents that it has not been formed for the specific purpose of acquiring the Securities. 
  
 4.4 Accredited Investor Status. The Investor is an “accredited investor” within the meaning of Regulation D. By reason of its business
and financial experience, sophistication and knowledge, the Investor is capable of evaluating the risks and merits of the investment made pursuant to this Agreement. The Investor confirms that it is able (a) to bear the economic risk of this
investment, as well as other risk factors as more fully set forth herein and in the SEC Documents, (b) to hold the Securities for an indefinite period of time and (c) to bear a complete loss of the Investor’s investment; and the Investor
represents that it has sufficient liquid assets so that the illiquidity associated with this investment will not cause any undue financial difficulties or affect the Investor’s ability to provide for its current needs and possible financial
contingencies. 
  

 6 

 4.5 Restricted Securities. The Investor understands that the Securities are characterized as
“restricted securities” under the 1933 Act inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under the 1933 Act and applicable regulations thereunder such securities may be
resold without registration under the 1933 Act only in certain limited circumstances. In this connection, the Investor represents that it is familiar with Rule 144 promulgated under the 1933 Act (“Rule 144”), as presently in effect,
and understands the resale limitations imposed thereby and by the 1933 Act. The Investor understands that the Company is under no obligation to register any of the securities sold hereunder except as provided in Section 9 hereof. 
  
 4.6 Due Diligence and No Solicitation. The Investor has had a
reasonable opportunity to ask questions of and receive answers from the Company and its officers, and all such questions have been answered to the full satisfaction of the Investor. At no time was the Investor presented with or solicited by any
leaflet, public promotional meeting, circular, newspaper or magazine article, radio or television advertisement or any other form of general advertising. 
  
 4.7 Further Limitations on Disposition. Without in any way limiting the representations set forth above, the Investor further agrees not to make
any disposition of all or any portion of the Securities unless and until: 
  
 (a) there is then in effect a registration statement under the 1933 Act covering such proposed disposition and such disposition is made in accordance with such registration statement; or 
  
 (b) (i) the Investor shall have notified the Company of the proposed
disposition and shall have furnished the Company with a statement of the circumstances surrounding the proposed disposition, and (ii) the Investor shall have furnished the Company at the Investor’s expense an opinion of counsel, reasonably
satisfactory to the Company that such disposition will not require registration of such securities under the 1933 Act; provided that the Company shall not require an opinion of counsel for routine sales of shares pursuant to Rule 144. 
  
 4.8 Legends. It is understood that the certificates evidencing the
Securities will bear the legends set forth below: 
  
 (a) THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAWS. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE
TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. 
  
 (b) The legend referred to in Section 4.8(a) above shall be removed from a certificate representing such Securities or shares of Common Stock issued upon
conversion thereof if the securities represented thereby are sold pursuant to an effective registration statement under the 1933 Act, or there is delivered to the Company such satisfactory 
  

 7 

 evidence, which may include an opinion of independent counsel, as reasonably may be requested by the Company, to confirm
that neither such legend nor the restrictions on transfer set forth therein are required to ensure that transfers of such securities will not violate the registration requirements of the 1933 Act. 
  
 5. PRE-CLOSING COVENANTS OF THE PARTIES. The Parties agree as
follows with respect to the period between the execution of this Agreement and the Closing: 
  
 5.1 General. Each of the Parties will use its reasonable best efforts to take all action and to do all things necessary, proper or advisable in order to consummate and make effective the transactions
contemplated by this Agreement (including satisfaction, but not waiver, of the closing conditions set forth in Sections 7 and 8 below). 
  
 5.2 Notice of Developments. Each Party will give prompt written notice to the other of any material adverse development causing a breach of any of
its own representations and warranties in Section 3 or 4 above. No disclosure by any Party pursuant to this Section 5.2, however, shall be deemed to cure any misrepresentation, breach of warranty or breach of covenant. 
  
 6. POST-CLOSING COVENANTS OF THE PARTIES. 
  
 6.1 Status of Dividends. The Company agrees to treat the Series B
Preferred as equity for all tax purposes unless the Company determines that there is no reasonable basis for such position. The Company shall take no action (other than as required by Law) that would jeopardize the availability of the dividends
received deduction under Section 243(a)(1) of the Internal Revenue Code of 1986, as amended, for the distributions on Series B Preferred that are paid out of current or accumulated earnings and profits, if any. 
  
 6.2 Listing; Reservation. 
  
 (a) So long as the Investors or their respective Affiliates Beneficially Own
any Securities, the Company shall use its best efforts to ensure that the shares of Common Stock continue to be quoted on the NASDAQ Stock Market; provided, however, this Section 6.2(a) shall not restrict the Company from engaging in
any reclassification, capital reorganization or other change in the outstanding shares of Common Stock or any consolidation or merger of the Company with or into another corporation or any other transaction in which the stockholders of the Company
are required to exchange their shares of Common Stock for stock or other securities of the Company or any other Person. “Beneficially Own” with respect to any securities means having “beneficial ownership” of such
securities (as determined pursuant to Rule 13d-3 promulgated under the 1934 Act as in effect on the date hereof, except that a Person shall be deemed to Beneficially Own all such securities that such Person has the right to acquire by conversion,
exercise of option or otherwise whether such right is exercisable immediately or after the passage of time). The terms “Beneficial Ownership” and “Beneficial Owner” have correlative meanings. 
  
 (b) From and after the Closing Date, the Company shall at all times reserve
and keep available, out of its authorized and unissued Common Stock, solely for the purpose of issuing Common Stock upon the conversion of the Shares, such number of shares of 
  

 8 

 Common Stock free of preemptive rights as shall be sufficient to issue Common Stock upon the conversion of the Shares.

  
 7. CONDITIONS TO THE INVESTORS’ OBLIGATIONS AT
CLOSING. The obligations of the Investors under Section 2 of this Agreement with respect to the Closing are subject to the fulfillment or waiver, on the Closing Date, of each of the following conditions: 
  
 7.1 Representations and Warranties True. The representations and
warranties of the Company contained in Section 3 qualified as to materiality shall be true and correct in all respects, and those not so qualified shall be true and correct in all material respects on and as of the Closing Date with the same effect
as though such representations and warranties had been made on and as of the Closing Date (except where such representation and warranty speaks by its terms as of a different date, in which case it shall be true and correct as of such date). The
Company shall have delivered to the Investors at the Closing a certificate in form and substance reasonably satisfactory to the Investors dated the Closing Date and signed by the chief executive officer and the chief financial officer or senior vice
president of accounting of the Company to the effect that the condition set forth in this Section 7.1 has been satisfied. 
  
 7.2 Compliance with Covenants. The Company shall have performed all of its obligations hereunder in all material respects and complied with all
agreements, undertakings, covenants and conditions required hereunder to be performed by it at or prior to the Closing. The Company shall have delivered to the Investors at the Closing a certificate in form and substance reasonably satisfactory to
the Investors dated the Closing Date and signed by the chief executive officer and the chief financial officer or senior vice president of accounting of the Company to the effect that the condition set forth in this Section 7.2 has been satisfied.

  
 7.3 No Litigation. 
  
 (a) No Law shall have been promulgated, enacted or entered that restrains,
enjoins, prevents, materially delays, prohibits or otherwise makes illegal the performance of this Agreement or the transactions contemplated hereby. 
  
 (b) No action, suit or proceeding shall be pending or threatened before any Governmental Authority wherein an unfavorable injunction, judgment, order,
decree, ruling or charge would (i) prevent, materially delay, prohibit or otherwise make illegal the consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions contemplated by this Agreement to be
rescinded following consummation (and no such injunction, judgment, order, decree, ruling or charge shall be in effect) or (iii) affect adversely the right of the Investors to own the Shares. 
  
 7.4 Securities Exemptions. The offer and sale of the Shares to the
Investors pursuant to this Agreement shall be exempt from the registration requirements of the 1933 Act, the qualification requirements of the California Corporate Securities Law of 1968 (the “California Securities Law”) and
the registration and/or qualification requirements of all other applicable state securities laws. 
  
 7.5 Certificate of Designations. The Series B Certificate shall have been filed with the Secretary of State of the State of Delaware and a copy of
the Series B Certificate, 
  

 9 

 certified by the Secretary of State of the State of Delaware, shall have been delivered to the Investors. 
  
 7.6 Shares. The Company shall have executed and delivered to the
Investors the certificates representing the Shares to be purchased by the Investors pursuant to Section 1.2 hereof. 
  
 7.7 Proceedings. All corporate and other proceedings to be taken by the Company in connection with this Agreement and with respect to the
transactions contemplated hereby to be completed at or prior to the Closing and documents incident thereto shall have been completed in form and substance reasonably satisfactory to the Investors, and the Investors shall have received all such
counterpart originals or certified or other copies of this Agreements and such other documents as it may reasonably request. 
  
 7.8 No Material Adverse Effect. No event shall have occurred and no condition shall have arisen or been created since the date of this Agreement
which has had, or would be reasonably likely to have, a Material Adverse Effect. 
  
 8. CONDITIONS TO THE COMPANY’S OBLIGATIONS AT CLOSING. The obligations of the Company to the Investors under this Agreement with respect to the Closing are subject to the fulfillment or waiver on
the Closing Date of each of the following conditions: 
  
 8.1
Representations and Warranties True. The representations and warranties of the Investors contained in Section 4 qualified as to materiality shall have been true and correct in all respects, and those not so qualified shall have been true and
correct in all material respects on and as of the Closing Date with the same effect as though such representations and warranties had been made on and as of the Closing Date (except where such representation and warranty speaks by its terms as of a
different date, in which case it shall be true and correct as of such date). 
  
 8.2 Payment of Consideration. The Investors shall have paid the Purchase Price in accordance with the provisions of Section 1.2. 
  
 8.3 No Litigation. 
  
 (a) No Law shall have been promulgated, enacted or entered that restrains, enjoins, prevents, materially delays, prohibits or otherwise makes illegal the
performance of this Agreement or the transactions contemplated hereby. 
  
 (b) No action, suit or proceeding shall be pending or threatened before any Governmental Authority wherein an unfavorable injunction, judgment, order, decree, ruling or charge would (i) prevent, delay, prohibit or otherwise make illegal the
consummation of any of the transactions contemplated by this Agreement, or (ii) cause any of the transactions contemplated by this Agreement to be rescinded following consummation (and no such injunction, judgment, order, decree, ruling or charge
shall be in effect). 
  

 10 

 8.4 Securities Exemptions. The offer and sale of the Shares to the Investors pursuant to this
Agreement shall be exempt from the registration requirements of the 1933 Act, the qualification requirements of the California Securities Law and the registration and/or qualification requirements of all other applicable state securities laws.

  
 9. Registration Statement for Resale of the
Shares. 
  
 9.1 Registration. As promptly as
practicable after the Closing but in any event within thirty (30) days following the Closing Date, the Company shall prepare and file with the SEC a registration statement on Form S-3 (the “Registration Statement”), and maintain effective
for the period specified in Section 9.2(a) for use by the Investors and their respective Affiliates at any time during such period with respect to the offering and sale or other disposition of the Conversion Shares. 
  
 9.2 Company Obligations. In the case of each registration effected by
the Company pursuant to this Section 9, the Company will keep the Investors, as applicable, advised in writing as to the initiation of each registration and as to the completion thereof. At its expense, the Company will: 
  
 (a) use its best efforts to cause such registration to remain effective at
all times until the earlier of (i) such time as the distribution described in the registration statement relating to the Conversion Shares has been completed and (ii) two (2) years from the Closing Date; 
  
 (b) prepare and file with the SEC such amendments and post-effective
amendments to such registration statement and supplements to the prospectus as may be (i) reasonably requested by the holders of a majority of the Conversion Shares, (ii) reasonably requested by any participating holder (to the extent such request
relates to information relating to such holder), or (iii) necessary to keep such registration effective for the period of time required by this Section 9; 
  
 (c) prepare and deliver to the Investors as many copies of each preliminary and final prospectus and other documents incident thereto as each of the
Investors from time to time may reasonably request; 
  
 (d)
immediately notify the Investors, at any time when a prospectus relating to a registration of Conversion Shares is required to be delivered under the 1933 Act, of the happening of any event as a result of which the prospectus included in such
registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and, at the request of the
Investors, prepare a supplement or amendment to such registration statement so that, as thereafter delivered to the purchasers of such Conversion Shares, such prospectus will not contain any untrue statement of a material fact or omit to state a
material fact required to be stated or necessary to make the statements therein not misleading; 
  
 (e) list the Conversion Shares on the automated quotation system and/or securities exchanges upon which the Common Stock is listed; 
  

 11 

 (f) use its best efforts to register or qualify and maintain the qualification of the Conversion Shares
covered by such registration under such state securities or “blue sky” laws for offers and sales to the public as the Investors shall reasonably request; provided, however, that the Company shall not be obligated to qualify
as a foreign corporation to do business under the laws of or become subject to taxation in, any jurisdiction in which it shall not be then qualified, or to file any general consent to service of process; 
  
 (g) otherwise use its best efforts to comply with the securities laws of the
United States and other applicable jurisdictions and all applicable rules and regulations of the SEC and comparable Governmental Authorities in other applicable jurisdictions; 
  
 (h) notify the Investors (i) when the Registration Statement or any amendment thereto has been filed or become effective,
when the prospectus or any amendment or supplement thereto has been filed and to furnish the Investors with copies thereof, (ii) of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement or any order
preventing or suspending the use of the preliminary prospectus or the Final Prospectus (as defined below) or the initiation or threatening of any proceedings for such purposes, and (iii) the receipt by the Company of any notification with respect to
the suspending of the qualification of the Conversion Shares for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and 
  
 (i) with a view to making available the benefits of certain rules and regulations of the SEC which may permit the sale of
restricted securities to the public without registration, the Company agrees to: (i) make and keep public information available as those terms are understood and defined in Rule 144; (ii) use its best efforts to file with the SEC in a timely manner
all reports and other documents required of the Company under the 1933 Act and the 1934 Act at any time after it has become subject to such reporting requirements; and (iii) so long as an Investor or transferee of an Investor owns any Securities,
furnish to such Investor or transferee of suchInvestor upon request, a written statement by the Company as to its compliance with the reporting requirements of Rule 144 and of the 1933 Act and the 1934 Act, a copy of the most recent annual or
quarterly report of the Company, and such other reports and documents so filed as suchInvestor or transferee of such Investor may reasonably request in availing itself of any rule or regulation of the SEC allowing such Investor or transferee of such
Investor to sell any such securities without registration. 
  
 9.3
Restrictions on Registrations. If at any time or from time to time after the effective date of the Registration Statement, the Company promptly notifies the Investors in writing of the existence of a Potential Material Event (as defined
below), the Investors shall not offer or sell any Conversion Shares or engage in any other transaction involving or relating to the Conversion Shares, from the time of the giving of notice with respect to a Potential Material Event until the
Investors receive written notice from the Company that such Potential Material Event either has been disclosed to the public or no longer constitutes a Potential Material Event. If a Potential Material Event shall occur prior to the date the
Registration Statement is filed, then notwithstanding Section 9.1 above, the Company’s obligation to file the Registration Statement shall be delayed until such Potential Material Event either has been disclosed to the public or no longer
constitutes a Potential Material Event. “Potential Material Event” means any of the following: (a) the possession by the Company of material information not ripe for disclosure in a 
  

 12 

 registration statement, as determined in good faith by the Chief Executive Officer or the Board of Directors that
disclosure of such information in a Registration Statement would be materially detrimental to the business and affairs of the Company; or (b) any material engagement or activity by the Company which would, in the good faith determination of the
Chief Executive Officer or the Board of Directors, be materially adversely affected by disclosure in a registration statement at such time, which determination shall be accompanied by a good faith determination by the Chief Executive Officer or the
Board of Directors that the applicable Registration Statement would be materially misleading absent the inclusion of such information. In no event shall the suspension of the Registration Statement (or the permissible delay in filing a Registration
Statement) (i) exceed ninety (90) days on any one occasion as a result of a Potential Material Event or (ii) be permitted more than once during any 12-month period. 
  
 9.4 Investor Obligations and Rights. 
  
 (a) Each of the Investors shall cooperate as reasonably requested by the Company with the Company in connection with the
preparation of the Registration Statement, and for so long as the Company is obligated to file and keep effective the Registration Statement, shall provide to the Company, in writing, for use in the Registration Statement, all such information
regarding such Investor and its plan of distribution of the Conversion Shares as may be reasonably necessary to enable the Company to prepare the Registration Statement and prospectus covering the Conversion Shares, to maintain the currency and
effectiveness thereof and otherwise to comply with all applicable requirements of law in connection therewith. Each of the Investors shall have the right to prepare any portions of the Registration Statement requiring information regarding such
Investor and its plan of distribution of the Conversion Shares. 
  
 (b) During such time as an Investor may be engaged in a distribution of the Conversion Shares, such Investor shall comply with Regulation M promulgated under the 1934 Act and pursuant thereto it shall, among other things; (i) not engage in
any stabilization activity in connection with the securities of the Company in contravention of such regulation; (ii) distribute the Conversion Shares under the Registration Statement solely in the manner described in the Registration Statement; and
(iii) cease distribution of such Conversion Shares pursuant to such Registration Statement upon receipt of written notice from the Company that the prospectus covering the Conversion Shares contains any untrue statement of a material fact or omits a
material fact required to be stated therein or necessary to make the statements therein not misleading. 
  
 (c) Each of the Investors hereby covenants with the Company not to make any sale of the Conversion Shares without effectively causing the prospectus
delivery requirements under the 1933 Act to be satisfied unless the sale is made pursuant to an exemption from registration. 
  
 (d) Each of the Investors acknowledges and agrees that the Conversion Shares sold pursuant to the Registration Statement are not transferable on the
books of the Company unless the stock certificate submitted to the transfer agent evidencing the Conversion Shares is accompanied by a certificate reasonably satisfactory to the Company to the effect that 
  

 13 

 (i) the Conversion Shares have been sold in accordance with this Agreement and the Registration Statement and (ii) the
requirement of delivering a current prospectus has been satisfied. 
  
 (e) Following termination of the effectiveness of the Registration Statement, each of the Investors shall discontinue sales of Conversion Shares pursuant thereto upon receipt of notice from the Company of its intention to remove from
registration the Conversion Shares covered thereby which remain unsold, and each of the Investors shall promptly notify the Company of the number of Conversion Shares registered that remain unsold immediately upon receipt of the notice from the
Company. 
  
 (f) Each of the Investors will observe and comply
with the 1933 Act, the 1934 Act and the general rules and regulations thereunder, as now in effect and as from time to time amended and including those hereafter enacted or promulgated, in connection with any offer, sale, pledge, transfer or other
disposition of the Conversion Shares or any part thereof. 
  
 9.5
Indemnification. 
  
 (a) The Company will indemnify and
hold harmless to the fullest extent permitted by law each of the Investors, as applicable, each of its Affiliates and each of their respective officers, directors, shareholders, employees, advisors, agents and partners, and each person controlling
each of the Investors, with respect to each registration which has been effected pursuant to this Section 9 against all Losses (as defined below) jointly and severally arising out of or based on any untrue statement (or alleged untrue statement) of
a material fact contained in any prospectus, offering circular or other document (including any amendment or supplement thereto or any documents incorporated by reference therein and any related registration statement, notification or the like)
incident to any such registration, qualification or compliance, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or any
violation by the Company of the 1933 Act or the 1934 Act or any rule or regulation thereunder applicable to the Company and relating to action or inaction required of the Company in connection with any such registration, qualification or compliance,
and will reimburse each of the Investors, each of its Affiliates and each of their respective officers, directors, shareholders, employees, advisors, agents and partners, and each person controlling each of the Investors for any legal and any other
expenses reasonably incurred in connection with investigating and defending any such Losses; provided, however, that the Company will not be liable in any such case to the extent that any such Losses arise out of or is based on any untrue statement
or omission based upon written information furnished to the Company by the Investors and stated expressly to be specifically for use therein. “Losses” shall mean, collectively, any and all losses, penalties, judgments, suits, costs,
claims, liabilities, damages and expenses (including, without limitation, reasonable attorneys’ fees and disbursements). 
  
 (b) Each of the Investors will, if Conversion Shares held by it are included in the securities as to which such registration, qualification or compliance
is being effected, indemnify and hold harmless to the fullest extent permitted by law the Company, each of its Affiliates and their respective directors, employees, advisors, agents and officers and each person who controls the Company, against all
Losses arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration 
  

 14 

 statement, prospectus, offering circular or other document made by such Investor in writing, or any omission (or alleged
omission) to state therein a material fact required to be stated therein or necessary to make the statements by such Investor therein not misleading, and will reimburse the Company and its directors, officers, partners, persons, or control persons
for any legal or any other expenses reasonably incurred in connection with investigating or defending any such Losses, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or
alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by such Investor and stated expressly to be specifically
for use therein; provided, however, that the obligations of each of the Investors hereunder shall be limited to an amount equal to the net proceeds to such Investor of securities sold as contemplated herein. 
  
 (c) Each party entitled to indemnification under this Section 9.5 (the
“Indemnified Party“) shall give notice to the party required to provide indemnification (the “Indemnifying Party“) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be
sought and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom; provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation resulting
therefrom, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld) and the Indemnified Party may participate in such defense at such party’s expense (unless (i) the Indemnifying Party has agreed in writing
to pay such fees or expenses, (ii) the Indemnifying Party shall have failed to assume the defense of such claim within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel
reasonably satisfactory to such Person, (iii) the Indemnified Party has reasonably concluded (based on the written advice of counsel) that there may be legal defenses available to it or other Indemnified Parties that are different from or in
addition to those available to the Indemnifying Party, or (iv) the Indemnified Party shall have reasonably concluded that there may be a conflict of interest between the Indemnifying Party and the Indemnified Party in such action, in which case the
fees and expenses of counsel shall be at the expense of the Indemnifying Party), and provided further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this
Section 9 unless the Indemnifying Party is materially prejudiced thereby. If such defense is not assumed by the Indemnifying Party, the Indemnifying Party will not be subject to any liability for any settlement made without its consent, but such
consent may not be unreasonably withheld. If the Indemnifying Party assumes the defense, the Indemnifying Party shall not have the right to settle such action without the written consent of the Indemnified Party. No Indemnifying Party, in the
defense of any such claim or litigation shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or
plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. Each Indemnified Party shall furnish such information regarding itself or the claim in question as an Indemnifying Party may reasonably
request in writing and as shall be reasonably required in connection with the defense of such claim and litigation resulting therefrom. 
  
 If the indemnification provided for in this Section 9.5 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with
respect to any Losses 
  

 15 

 referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall
contribute to the amount paid or payable by such Indemnified Party as a result of such Losses in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in
connection with the statements or omissions which resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be
determined by reference to, among other things, whether the untrue (or alleged untrue) statement of a material fact or the omission (or alleged omission) to state a material fact relates to information supplied by the Indemnifying Party or by the
Indemnified Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. Notwithstanding anything in this Section 9.5 to the contrary, no Indemnifying Party (other
than the Company) shall be required pursuant to this Section 9.5 to contribute any amount in excess of the amount by which the net proceeds received by such Indemnifying Party from the sale of Conversion Shares in the offering to which the Losses of
the Indemnified Party relates exceeds the amount of any damages which such Indemnifying Party has otherwise been required to pay by reason of such untrue statement or omission.  
  
 The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 9.5 were
determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
  
 (d) The foregoing indemnity agreement of the Company and Investors is subject to the condition that, insofar as they relate to any Losses made in a
preliminary prospectus but eliminated or remedied in the amended prospectus on file with the SEC at the time the registration statement in question becomes effective or the amended prospectus filed with the SEC pursuant to Rule 424(b) promulgated
under the 1933 Act (the “Final Prospectus“), such indemnity or contribution agreement shall not inure to the benefit of an Investor if a copy of the Final Prospectus was timely furnished to such Investor in sufficient quantities for
delivery and was not furnished to the person asserting the loss, liability, claim or damage at or prior to the time such action is required by the 1933 Act. 
  
 (e) Notwithstanding any other provision of this Agreement, the obligations of the parties under this Section 9.5 shall survive indefinitely. 

 
 9.6 Expenses. The Company shall pay all expenses incident to the
registration of the Conversion Shares under this Section 9 including without limitation, all registration, listing, quotation and filing fees, all fees and expenses of complying with securities or blue sky laws, all word processing, duplicating and
printing expenses, and the fees and disbursements of counsel for the Company and its independent public accountants. With respect to sales of the Conversion Shares, the Investors shall pay all underwriting discounts and commissions and fees of
underwriters, selling brokers, dealer managers or similar securities industry professionals relating to the distribution of the Conversion Shares to be sold by the Investors, the fees and disbursements of counsel retained by the Investors and
transfer taxes, if any. 
  

 16 

 10. TERMINATION 
  
 10.1 Termination. This Agreement may be terminated at any time prior to the Closing: 
  
 (a) by mutual written agreement of the Company and the Investors;

  
 (b) by either the Investors or the Company (provided that the
terminating Party is not then in material breach of any representation, warranty, covenant or other agreement contained in this Agreement) if the Closing shall not have been consummated on or before July 31, 2003; 
  
 (c) by either the Investors or the Company if a court of competent
jurisdiction or a Governmental Authority shall have issued a non-appealable final judgment, injunction, order, ruling or decree or taken any other action having the effect of permanently restraining, enjoining or otherwise prohibiting the
transactions contemplated by this Agreement provided that the Party seeking to terminate this Agreement pursuant to this clause (c) shall have used its reasonable best efforts to have such judgment, injunction, order, ruling or decree lifted,
vacated or denied; or 
  
 (d) by either the Investors or the
Company (provided that the terminating Party is not then in material breach of any representation, warranty, covenant or other agreement contained in this Agreement) in the event of a material breach by the other Party of any representation or
warranty contained in this Agreement which cannot be or has not been cured within thirty (30) days after the giving of written notice to the breaching Party of such breach. 
  
 10.2 Effect of Termination. In the event of the termination of this Agreement pursuant to Section 10.1, this
Agreement shall forthwith become void and there shall be no liability on the part of any Party hereto (or any stockholder, director, officer, partner, employee, agent, consultant or representative of such Party) except as set forth in this Section
10.2, provided that nothing contained in this Agreement shall relieve any party from liability for any breach of this Agreement and provided further that Section 11 shall survive termination of this Agreement. 
  
 11. MISCELLANEOUS. 
  
 11.1 Survival of Warranties. The representations and warranties of the
Company and the Investors contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the Closing for a period of twenty-four (24) months from the Closing Date and shall in no way be affected by any
knowledge or investigation of the subject matter thereof made by or on behalf of the Investors or the Company, as the case may be. 
  
 11.2 Specific Performance. The parties hereto specifically acknowledge that monetary damages are not an adequate remedy for violations of this
Agreement, and that any party hereto may, in its sole discretion, apply to a court of competent jurisdiction for specific performance or injunctive or such other relief as such court may deem just and proper in order to 
  

 17 

 enforce this Agreement or prevent any violation hereof and, to the extent permitted by applicable Law and to the extent
the party seeking such relief would be entitled on the merits to obtain such relief, each party waives any objection to the imposition of such relief. 
  
 11.3 Successors and Assigns 
  
 (a) This Agreement shall bind and inure to the benefit of the Company and the Investors and their respective successors, permitted assigns, heirs and
personal representatives; provided that the Company may not assign its rights or obligations under this Agreement to any Person without the prior written consent of the Investors. 
  
 (b) Nothwithstanding Section 11.3(a) or any other provision to the contrary in this Agreement, the Investors may assign any
and all of their rights and obligations under Section 9 hereof in connection with the transfer to such assignee of at least 1,000 Shares (or the Conversion Shares issued upon conversion thereof). 
  
 11.4 Governing Law 
 . 
 (a) This Agreement shall be governed by and construed
under the internal laws of the State of California as applied to agreements among California residents entered into and to be performed entirely within that State, without reference to principles of conflict of laws or choice of law thereof.

  
 (b) The Parties hereto hereby agree that the appropriate and
exclusive forum for any disputes arising out of this Agreement solely between the Company and any of the Investors shall be the United States District Court for the Southern District of California, and, if such court will not hear any such suit, the
courts of the state of Delaware, and the parties hereto hereby irrevocably consent to the exclusive jurisdiction of such courts, and agree to comply with all requirements necessary to give such courts jurisdiction. The Parties hereto further agree
that the Parties will not bring suit with respect to any disputes arising out of this Agreement except as expressly set forth below for the execution or enforcement of judgment, in any jurisdiction other than the above specified courts. Each of the
Parties hereto irrevocably consents to the service of process in any action or proceeding hereunder by the mailing of copies thereof by registered or certified airmail, postage prepaid, to the address specified in Section 11.7 hereof. The foregoing
shall not limit the rights of any party hereto to serve process in any other manner permitted by the law or to obtain execution of judgment in any other jurisdiction. The Parties further agree, to the extent permitted by law, that final and
unappealable judgment against any of them in any action or proceeding contemplated above shall be conclusive and may be enforced in any other jurisdiction within or outside the United States by suit on the judgment, a certified or exemplified copy
of which shall be conclusive evidence of the fact and the amount of indebtedness. 
  
 11.5 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 11.6 Headings. The headings and captions used in this Agreement are
used for convenience only and are not to be considered in construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs, exhibits and schedules shall, unless 
  

 18 

 otherwise provided, refer to sections and paragraphs hereof and exhibits and schedules attached hereto, all of which
exhibits and schedules are incorporated herein by this reference. 
  
 11.7 Notices. All notices, requests, demands, claims and other communications hereunder will be in writing. Any notice, request, demand, claim or other communication hereunder shall be deemed duly given if (and then four (4) Business
Days after) it is sent by registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient as set forth below: 
  
 To the Company:       PriceSmart, Inc. 
 4649 Morena Boulevard 
 San Diego, CA 92117-3650 
 Attention: Robert M. Gans, Esq. 
 Telephone: (858) 581-7726 
 Facsimile: (858) 581-4707 
  
 with
a copy to:           Latham & Watkins LLP 
 12636 High Bluff
Drive, Suite 300 
 San Diego, CA 92130 
 Attention: Robert E. Burwell, Esq. 
 Telephone: (858) 523-5400 
 Facsimile: (858) 523-5450 
  
 To the Investors:       To the names and
addresses set forth 
 on the signature pages hereto 
  
 Any Party may send any notice, request, demand, claim or other communication hereunder to the intended recipient at the address set forth
above using any other means (including personal delivery, expedited courier, messenger service or ordinary mail), but no such notice, request, demand, claim or other communication shall be deemed to have been duly given unless and until it actually
is received by the intended recipient. Any Party may change the address to which notices, requests, demands, claims and other communications hereunder are to be delivered by giving the other Parties notice in the manner herein set forth. 

 
 11.8 No Finder’s Fees. Each party represents that it neither
is nor will be obligated for any finder’s or broker’s fee or commission in connection with this transaction. The Company agrees to indemnify and hold harmless each of the Investors from any liability for any commission or compensation in
the nature of a finder’s or broker’s fee (and any asserted liability) for which the Company or any of its officers, employees or representatives is responsible. 
  

 19 

 11.9 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any
term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Investors. 
  
 11.10 Attorneys’ Fees. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.

  
 11.11 Severability. If one or more provisions of this
Agreement are held to be unenforceable under applicable law, such provision(s) shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in
accordance with its terms. 
  
 11.12 Entire Agreement. This
Agreement, together with all exhibits and schedules hereto, constitutes the entire agreement and understanding of the parties with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements,
understandings duties or obligations between the Parties with respect to the subject matter hereof. 
  
 11.13 No Third Party Beneficiaries. This Agreement is for the sole benefit of the Parties hereto and their respective successors and permitted
assigns and nothing herein, express or implied, is intended or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, except that the provisions of Section
9.5 shall inure to the benefit of and be enforceable by each Indemnified Party. 
  
 11.14 Public Announcements.The Investors and the Company shall consult with each other before issuing any press release with respect to this Agreement or the transactions contemplated hereby and neither shall
issue any such press release or make any such public statement without the prior consent of the other, which consent shall not be unreasonably withheld; provided, however, that a Party may, without the prior consent of the other Party,
issue such press release or make such public statement as may upon the advice of counsel be required by law if it has used commercially reasonable efforts to consult with the other Party prior thereto. The Parties hereby consent to the filing of
this Agreement by the Company and a Schedule 13D and Form 4 by each of the Investors, as applicable, with the SEC. 
  
 11.15 Further Assurances. From and after the date of this Agreement, upon the request of any of the Investors or the Company, the Company and the
Investors shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement. 
  
 11.16 Fees and Expenses. Except as otherwise provided in this
Agreement, each of the Parties shall each bear its own expenses incurred in connection with the negotiation and 
  

 20 

 execution of this Agreement and each other agreement, document and instrument contemplated by this Agreement and the
consummation of the transactions contemplated hereby and thereby. 
  
 11.17 Waiver of Jury Trial. THE COMPANY AND THE INVESTORS HEREBY WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, PROCEEDING OR LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH
THIS AGREEMENT. 
  
 [Remainder of Page Intentionally Left Blank]

  

 21 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

  
 THE COMPANY: 
  
  
 PRICESMART, INC. 
  

		
	 By:
	 	 /s/    ROBERT M. GANS
        

	 Name:
	 	Robert M. Gans
	 Title:
	 	Executive Vice President and General Counsel

  
 THE INVESTORS: 
  

		
	 By:
	 	 /s/    SOL PRICE

	 Name:
	 	 Sol Price

	 Title:
	 	 Trustee

  
 Address: 7979 Ivanhoe Avenue, #520 
 La Jolla, California 92037 
  
 Facsimile: (858) 551-2314 
 Phone:       (858) 551-2311 
  
 THE PRICE FAMILY CHARITABLE FUND 
  

		
	 By:
	 	 /s/    SOL
PRICE        

	 Name:
	 	 Sol Price

	 Title:
	 	 Director

  
 Address: 7979 Ivanhoe Avenue, #520 
 La Jolla, California 92037 
  
 Facsimile: (858) 551-2314 
 Phone:       (858) 551-2311 
  

 22 

 THE PRICE GROUP LLC 
  

		
	 By:
	 	 /s/    JAMES CAHILL
        

	 Name:
	 	 James Cahill

	 Title:
	 	 Manager

  
 Address: 7979 Ivanhoe Avenue, #520 
 La Jolla, California 92037 
  
 Facsimile: (858) 551-2314 
 Phone:       (858) 551-2311 
  
 ROBERT & ALLISON PRICE CHARITABLE REMAINDER TRUST 
  

		
	 By:
	 	 /s/    ROBERT E. PRICE
        

	 Name:
	 	 Robert E. Price

	 Title:
	 	 Trustee

  

		
	 By:
	 	 /s/    ALLISON
PRICE        

	 Name:
	 	 Allison Price

	 Title:
	 	 Trustee

  
 Address: 7979 Ivanhoe Avenue, #520 
 La Jolla, California 92037 
  
 Facsimile: (858) 551-2314 
 Phone:       (858) 551-2311 
  
 ROBERT & ALLISON PRICE TRUST 1/10/75 
  

		
	 By:
	 	 /s/    ROBERT E.
PRICE        

	 Name:
	 	 Robert E. Price

	 Title:
	 	 Trustee

  

		
	 By:
	 	 /s/    ALLISON
PRICE        

	 Name:
	 	 Allison Price

	 Title:
	 	 Trustee

  
 Address: 7979 Ivanhoe Avenue, #520 
 La Jolla, California 92037 
  
 Facsimile: (858) 551-2314 
 Phone:       (858) 551-2311 
  

 23 

 SCHEDULE 3.4(b) 
  
 Piggyback: Under a Common Stock Purchase Agreement dated April 12, 2002 (the “IFC Purchase Agreement”), if the Company proposes to
register any shares of its Common Stock in connection with an underwritten public offering, International Finance Corporation (“IFC”) possesses piggyback registration rights to require the Company to include up to an aggregate of 300,000
shares of the Company’s Common Stock in such registration on the same terms and conditions as the securities otherwise being sold through the underwriters. These piggyback registration rights are in effect until the earlier of (1) such time as
IFC has completed the resale of its shares, (2) such time as IFC is able to freely sell its shares without registration and without regard to volume or manner of sale and (3) two years from IFC’s purchase of the shares. 
  
 Other registration rights: 
  

	 	1.	 	Under a Registration Rights Agreement dated June 3, 2000, PSC, S.A. (“PSC”) possesses registration rights with respect to an aggregate of 679,500 shares of the
Company’s Common Stock. Pursuant to the Registration Rights Agreement, the Company filed registration statements on Form S-3 on July 27, 2000 and August 8, 2001, which were subsequently declared effective. PSC has the right to require that the
registration statement be kept effective until PSC or a permitted assignee has completed the distribution of its shares as described in the registration statements. 

  

	 	2.	 	Under Series A Preferred Stock Purchase Agreements dated January 15, 2002 and January 18, 2002, Grupo Gigante, S.A. de C.V., The Price Family Charitable Fund, The Price Family
Charitable Trust, The Sol and Helen Price Trust, Oppenheimer—Close Investment Partnership, L.P., P. Oppenheimer Investment Partnership, L.P., Performance Capital II, Little Wing LP, Trade Winds Fund Ltd., Terrier Partners LP, Wynnefield
Partners Small Cap Value, LP, Wynnefield Partners Small Cap Value, LP I, and Wynnefield Small Cap Value Offshore Fund, Ltd. (collectively, the “Series A Investors”) possess registration rights with respect to an aggregate of 533,329 shares
of the Company’s Common Stock. Pursuant to the Series A Preferred Stock Purchase Agreements, the Company filed a registration statement on Form S-3 on February 26, 2002, which was subsequently declared effective. The Series A Investors have the
right to require that the registration statement be kept effective until the earlier of (1) such time as the Series A Investors have completed the distribution of their shares as described in the registration statement and (2) two years from their
purchase of the shares of Series A Preferred Stock. 

  

	 	3.	 	Under the IFC Purchase Agreement, IFC possesses registration rights with respect to an aggregate of 300,000 shares of the Company’s Common Stock. Pursuant to the IFC Purchase
Agreement, the Company filed a registration statement on Form S-3 on April 18, 2002, which was subsequently declared effective. IFC has the right to require that the registration statement be kept effective until the earlier of (1) such time as IFC
is able to freely sell its shares without registration and without regard to volume or manner of sale and (2) two years from its purchase of the shares. 

	 	4.	 	Under Common Stock Purchase Agreements dated June 24, 2002, Green Hill Investments, Inc., Chancellor Holdings Limited and Nithyananda Ent. Ltd. (collectively, the “GCN
Investors”) possess registration rights with respect to an aggregate of 47,808 shares of the Company’s Common Stock. Pursuant to the Common Stock Purchase Agreements, the Company filed a registration statement on Form S-3 on July 19, 2002,
which was subsequently declared effective. The GCN Investors have the right to require that the registration statement be kept effective until the earlier of (1) such time as the GCN Investors are able to freely sell their shares without
registration and without regard to volume or manner of sale and (2) two years from their purchase of the shares. 

  

	 	5.	 	Under a Common Stock Purchase Agreement dated August 9, 2002, PSC possesses registration rights with respect to an aggregate of 79,313 shares of the Company’s Common Stock.
Pursuant to the Common Stock Purchase Agreement, the Company filed a registration statement on Form S-3 on October 25, 2002, which was subsequently declared effective. PSC has the right to require that the registration statement be kept effective
until the earlier of (1) such time as PSC is able to freely sell its shares without registration and without regard to volume or manner of sale and (2) two years from its purchase of the shares. 

 EXHIBIT A 
  

Schedule of Investors 
  

	 Investor

	  	Number of Shares

	  	Aggregate Purchase Price

	 Sol and Helen Price Trust
	  	7,000	  	$  7,000,000
	 The Price Family Charitable Fund
	  	5,000	  	$  5,000,000
	 The Price Group LLC
	  	5,000	  	$  5,000,000
	 Robert & Allison Price Charitable Remainder Trust
	  	3,000	  	$  3,000,000
	 Robert & Allison Price Trust 1/10/75
	  	2,000	  	$  2,000,000
	 	  	
	  	

	 TOTAL
	  	22,000	  	$22,000,000
	 	  	
	  	

 EXHIBIT B 
  

Certificate of Designations

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}]]